Evidence map›Paper›PMID 30846496›Full record

Trial reportHaematologica2019

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

Chloé B Steen, Ellen Leich, June H Myklebust, Sandra Lockmer, Jillian F Wise, Björn E Wahlin, Bjørn Østenstad, Knut Liestøl, Eva Kimby, Andreas Rosenwald and 4 more

Abstract readLetterRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chloé B SteenDepartment of Informatics, University of Oslo, Oslo, Norway.
Ellen LeichInstitute of Pathology, University of Würzburg and Comprehensive Cancer Centre Mainfranken, Germany.
June H MyklebustDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Sandra LockmerDivision of Haematology, Department of Medicine at Huddinge, Karolinska Institute and University Hospital, Stockholm, Sweden.
Jillian F WiseDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Björn E WahlinDivision of Haematology, Department of Medicine at Huddinge, Karolinska Institute and University Hospital, Stockholm, Sweden.
Bjørn ØstenstadDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Knut LiestølDepartment of Informatics, University of Oslo, Oslo, Norway.
Eva KimbyDivision of Haematology, Department of Medicine at Huddinge, Karolinska Institute and University Hospital, Stockholm, Sweden.
Andreas RosenwaldInstitute of Pathology, University of Würzburg and Comprehensive Cancer Centre Mainfranken, Germany.
Erlend B SmelandDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Harald HolteKG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Ole Christian LingjærdeDepartment of Informatics, University of Oslo, Oslo, Norway ole@ifi.uio.no.
Marianne BrodtkorbDepartment of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway meide@ous-hf.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Transformation, NeoplasticGene Expression Regulation, NeoplasticImmunotherapyLymphoma, FollicularFemaleHumansMaleMiddle AgedProspective Studies

Identifiers

PMID30846496
PMCPMC6886427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.